acetylcysteine has been researched along with Compensatory Hyperinsulinemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Kareem, DM; Almaz, D; El Shehaby, DM; Elsherif, R; Sayed, SA | 1 |
| Baskaran, SK; Lakshmi, BS; Posa, JK; Sangeetha, KN; Selvaraj, S | 1 |
| Muderris, II; Oner, G | 1 |
| Delvin, E; Lambert, M; Levy, E; Seidman, E; Ziv, E; Zoltowska, M | 1 |
| Adachi, Y; Sakurai, H; Yoshikawa, Y | 1 |
| Ayala, GF; Belosi, C; Ciampelli, M; Fulghesu, AM; Lanzone, A; Muzj, G; Selvaggi, L | 1 |
2 trial(s) available for acetylcysteine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
Topics: Acetylcysteine; Adolescent; Adult; Anticholesteremic Agents; Antioxidants; Body Mass Index; Female; Hirsutism; Humans; Hyperandrogenism; Hypercholesterolemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Menstruation Disturbances; Metformin; Patient Dropouts; Polycystic Ovary Syndrome; Severity of Illness Index; Tumor Necrosis Factor-alpha; Young Adult | 2011 |
N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.
Topics: Acetylcysteine; Adult; Androgens; Drug Administration Schedule; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2002 |
4 other study(ies) available for acetylcysteine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Trimetazedine with hyperinsulinimea-euoglycemia, N-acetyl cysteine, and vitamin C: A new approach concept for management of aluminum phosphide poisoning.
Topics: Acetylcysteine; Aluminum Compounds; Animals; Ascorbic Acid; Hyperinsulinism; Male; Phosphines; Rabbits; Trimetazidine | 2022 |
p53 mediates impaired insulin signaling in 3T3-L1 adipocytes during hyperinsulinemia.
Topics: 3T3-L1 Cells; Acetylcysteine; Adipocytes; Animals; Cell Differentiation; Free Radical Scavengers; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Mice; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53 | 2014 |
Both insulin resistance and diabetes in Psammomys obesus upregulate the hepatic machinery involved in intracellular VLDL assembly.
Topics: Acetylcysteine; Animals; Apolipoproteins B; Cells, Cultured; Cysteine Endopeptidases; Diabetes Mellitus; Disease Models, Animal; Gerbillinae; Hepatocytes; Hypercholesterolemia; Hyperinsulinism; Hypertriglyceridemia; Insulin; Insulin Resistance; Leupeptins; Lipoproteins, VLDL; Liver; Multienzyme Complexes; Protease Inhibitors; Proteasome Endopeptidase Complex | 2004 |
Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities.
Topics: Acetylcysteine; Adipocytes; Animals; Antioxidants; Blood Glucose; Blood Urea Nitrogen; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Evaluation, Preclinical; Glucose Tolerance Test; Hemoglobins; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Oxidative Stress; Rats; Rats, Wistar; Zinc | 2007 |